Surfactants for use in healthcare products

A liquid formulation for healthcare, comprising:

• at least one surfactant of Formula I,
• wherein R1 and R2 may be the same or different, and comprise at least one group selected from the group consisting of C1-C6 alkyl, optionally the C1-C6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;
• n is an integer from 1 to 12;
• the terminal nitrogen is optionally further substituted with R3, wherein R3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C1-C6 alkyl;
• an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide;
• at least one Active ingredient;
• and
• an aqueous component.

An emulsion for healthcare, comprising:

• at least one surfactant of Formula I,
• wherein R1 and R2 may be the same or different, and comprise at least one group selected from the group consisting of C1-C6 alkyl, optionally the C1-C6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate;
• n is an integer from 1 to 12;
• the terminal nitrogen is optionally further substituted with R3, wherein R3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C1-C6 alkyl;
• an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide;
• and
• at least one Active ingredient;
• an aqueous phase;
• and
• a non-aqueous phase.